Urinary tract and prostate
5α-Reductase inhibitors
Drugs that block the conversion of testosterone to dihydrotestosterone, shrinking an enlarged prostate over months; they halve the PSA level, which must be taken into account when screening for cancer.
طریقۂ عمل
- 5α-Reductase converts testosterone into dihydrotestosterone (DHT), the androgen that drives prostate growth.
- Finasteride inhibits the type 2 enzyme; dutasteride inhibits types 1 and 2.
- DHT in the prostate falls, the gland shrinks by up to about a quarter over six months or more, and the risk of urinary retention falls.
Molecular targets
- 5α-Reductase: Inhibitor
5α-Reductase inhibitors کی ادویات
- Finasteride (Type 2 inhibitor.)
- Dutasteride (Types 1 and 2.)
علاج میں استعمال
- Benign prostatic hyperplasia with a large gland, alone or with an α1-blocker
- Male-pattern hair loss (finasteride)
جن بیماریوں کا علاج کرتی ہے
مضر اثرات
- Reduced libido, erectile and ejaculatory dysfunction
- Gynaecomastia
حالت کے لحاظ سے ممانعت
- Pregnancy (exposure, including handling crushed tablets) (ممنوع): Blocking DHT feminises the genitalia of a male fetus.
- Prostatic adenocarcinoma (احتیاط سے): The lower PSA can hide a rising cancer unless corrected.
دیگر احتیاطیں اور interactions
- They lower PSA by about half: a measured PSA must be doubled when assessing prostate cancer risk.
جڑے ہوئے موضوعات
ماخذ
- Lippincott Illustrated Reviews: Pharmacology, 7th ed., Ch. 41, Drugs for Urologic Disorders, 5α-Reductase inhibitors
- Basic & Clinical Pharmacology (Katzung), 14th ed., Ch. 40, The Gonadal Hormones & Inhibitors, Inhibitors of steroid synthesis: 5α-reductase
تعلیمی حوالہ۔ طبی مشورہ، تشخیص یا علاج نہیں۔